| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥528.6B | ¥513.2B | +3.0% |
| Operating Income | ¥56.5B | ¥68.4B | -17.4% |
| Ordinary Income | ¥54.5B | ¥69.7B | -21.7% |
| Net Income | ¥30.8B | ¥47.8B | -35.4% |
| ROE | 6.3% | 9.8% | - |
FY2025 full-year results show revenue of 528.6B yen (YoY +3.0%) maintaining growth momentum, while operating income declined to 56.5B yen (YoY -17.4%), ordinary income fell to 54.5B yen (YoY -21.7%), and net income decreased to 30.8B yen (YoY -35.4%). Despite revenue expansion, profitability contracted significantly with operating margin declining to 10.7% from prior year's higher level. The company maintained a robust gross profit margin of 62.8% at 331.8B yen, but SG&A expenses of 275.2B yen (52.1% of revenue) weighed heavily on operating profit. Basic EPS declined to 106.26 yen from 154.12 yen YoY (-31.1%). Operating cash flow of 53.8B yen remained healthy at 1.57x net income, demonstrating solid cash generation capability despite profit decline. Free cash flow of 23.7B yen was generated after capital expenditure of 29.5B yen, though total shareholder returns including share buybacks of 20.0B yen and dividends created significant cash outflow via financing activities of -48.6B yen.
Revenue increased 3.0% YoY to 528.6B yen, reflecting steady top-line growth. The company operates in a single business segment of cosmetics manufacturing and sales. Cost of sales rose to 196.9B yen, resulting in gross profit of 331.8B yen with a gross margin of 62.8%, indicating strong pricing power and favorable product mix. However, SG&A expenses climbed to 275.2B yen, representing 52.1% of revenue, which compressed operating margin. Operating income declined 17.4% to 56.5B yen (operating margin 10.7%), suggesting that SG&A growth outpaced revenue growth. Non-operating items showed a net negative contribution of approximately 2.0B yen, with equity method losses of 0.3B yen and minor foreign exchange gains of 0.7B yen offset by other non-operating expenses totaling 3.3B yen. The gap between ordinary income (54.5B yen) and profit before tax (49.3B yen) widened due to extraordinary losses of 8.2B yen, primarily from loss on valuation of investment securities of 8.1B yen, representing a non-recurring negative factor. This investment valuation loss was partially offset by gain on sale of assets of 2.9B yen. Income tax expense of 14.9B yen resulted in net income of 30.8B yen. The significant divergence between operating income and net income (45.5% decline from operating to net) stems from the combination of non-operating losses and extraordinary items, particularly the securities valuation loss. This represents a "revenue up, profit down" pattern, driven by elevated SG&A expenses and one-time investment-related losses that overshadowed stable gross profitability.
[Profitability] ROE stood at 6.3%, declining from higher prior year levels as net income contracted. Operating margin of 10.7% represents a decrease from the previous period, primarily driven by SG&A expense pressure. Gross profit margin remained robust at 62.8%, demonstrating maintained product pricing strength. Net profit margin compressed to 5.8% from higher levels due to operating profit decline and extraordinary losses. [Cash Quality] Cash and deposits totaled 118.2B yen with current assets of 291.0B yen, providing strong liquidity coverage. The company generated operating cash flow of 53.8B yen, representing 1.57x net income coverage, indicating healthy earnings quality with solid cash conversion. Free cash flow of 23.7B yen remained positive. [Investment Efficiency] Total asset turnover was 0.915x. Capital expenditure of 29.5B yen exceeded depreciation of 23.2B yen by 1.27x, indicating continued growth and renewal investments. Inventory turnover showed extended holding periods with inventories at 80.0B yen, suggesting working capital efficiency requires attention. [Financial Health] Equity ratio stood at 84.9%, reflecting an extremely conservative capital structure. Current ratio of 378.7% and quick ratio of 274.5% indicate excellent short-term liquidity position. Debt-to-equity ratio remained minimal at approximately 0.18x with total liabilities of 87.4B yen against equity of 490.6B yen, demonstrating strong financial stability. Net defined benefit liability was minimal at 0.2B yen.
Operating cash flow of 53.8B yen represented 1.57x net income, confirming cash-backed earnings quality despite the YoY decline of 29.4%. The operating cash flow subtotal before working capital changes was 74.7B yen, with working capital movements showing inventory increase of 1.2B yen and modest improvements in receivables contributing 1.0B yen, while payables decreased 0.5B yen. Income taxes paid amounted to 21.1B yen. Investing cash flow of -30.1B yen was primarily driven by capital expenditure of 29.5B yen, with the CapEx-to-depreciation ratio of 1.27x indicating active investment in facility renewal and expansion. Financing cash flow of -48.6B yen reflected significant shareholder returns through share buybacks of 20.0B yen and dividend payments totaling approximately 28.6B yen. Free cash flow of 23.7B yen (operating CF minus investing CF) was generated, though total shareholder distributions exceeded FCF, resulting in a coverage ratio of 0.83x. This cash allocation strategy, while rewarding shareholders generously, places pressure on internal cash reserves. Interest and dividends received contributed 0.3B yen to operating activities.
Ordinary income of 54.5B yen versus operating income of 56.5B yen shows a non-operating net negative contribution of approximately 2.0B yen. Non-operating items comprised equity method losses of 0.3B yen, foreign exchange gains of 0.7B yen, interest and dividend income of 0.3B yen, offset by other non-operating expenses totaling 3.3B yen including foreign exchange losses of 0.5B yen. The most significant earnings quality concern stems from extraordinary items, where extraordinary losses of 8.2B yen (primarily loss on valuation of investment securities of 8.1B yen) substantially impacted profit before tax, representing a non-recurring factor. This was partially offset by extraordinary income of 2.9B yen from asset sales. These investment-related valuation losses and asset disposal activities represent approximately 1.0% of revenue in net extraordinary impact, indicating material one-time influences on reported earnings. Operating cash flow of 53.8B yen exceeded net income of 30.8B yen by 1.75x, indicating healthy underlying earnings quality when isolating core business performance from non-recurring items. The cash conversion quality remains sound despite extended inventory holding periods flagged in working capital metrics.
Full-year guidance shows revenue forecast of 548.0B yen (YoY +3.7%), operating income of 63.0B yen (YoY +11.4%), ordinary income of 61.8B yen (YoY +13.3%), and EPS forecast of 135.30 yen with dividend forecast of 40.00 yen. Current period progress against full-year targets stands at revenue 96.5%, operating income 89.7%, and ordinary income 88.2%. The revenue achievement rate of 96.5% exceeds the typical full-year pace, suggesting conservative guidance or strong year-end momentum expected. Operating income achievement of 89.7% indicates an anticipated recovery in profitability during the remaining period, implying management expects improved cost control or reduced one-time expenses. The forecasted operating income improvement of 11.4% YoY contrasts with the current period's -17.4% decline, signaling expected normalization from extraordinary factors and potential SG&A expense management initiatives. The forecast assumes reversal of investment valuation losses and stabilization of cost structure. The projected EPS of 135.30 yen represents recovery from current period's 106.26 yen, requiring net income to reach approximately 43.0B yen based on share count, implying significant profit improvement in final periods or subsequent fiscal year.
Annual dividend totals 88.00 yen per share, comprising interim dividend of 40.00 yen and year-end dividend of 48.00 yen. Based on current period net income attributable to owners and average shares outstanding, the calculated payout ratio reaches approximately 82.7%, representing an elevated dividend commitment relative to earnings. Total dividend payments amounted to approximately 28.6B yen in cash outflow. Share buybacks of 20.0B yen were executed during the period, bringing total shareholder returns (dividends plus buybacks) to approximately 48.6B yen. The total return ratio (combined dividends and buybacks relative to net income) exceeds 100%, standing at approximately 158%, indicating shareholder distributions surpassed current period earnings. Free cash flow of 23.7B yen provided 49% coverage of total shareholder returns, with the remainder funded by existing cash reserves. This aggressive capital return policy demonstrates strong commitment to shareholder value but raises sustainability considerations if profitability does not recover as forecasted. The company's substantial cash position of 118.2B yen and strong balance sheet provide buffer for maintaining distributions despite temporary earnings pressure.
Inventory management deterioration poses the primary operational risk, with extended inventory holding periods indicating potential obsolescence exposure and working capital inefficiency. The significant inventory balance of 80.0B yen requires active management to prevent cash flow deterioration and potential write-down risks. Investment portfolio volatility represents a material earnings risk factor, evidenced by the 8.1B yen valuation loss on investment securities in the current period. The investment securities balance declined 26.6% from 8.8B yen to 6.4B yen, and continued market volatility could generate additional non-operating losses that impact reported profitability and comprehensive income. SG&A expense control challenges present structural profitability risk, with SG&A at 52.1% of revenue compressing operating margins. If SG&A growth continues to outpace revenue growth, sustained margin pressure will constrain earnings recovery and return on equity improvement, requiring management focus on cost structure optimization.
[Industry Position] (Reference - Proprietary Analysis) The company demonstrates distinctive characteristics within the cosmetics manufacturing and sales industry through its exceptionally strong gross profit margin of 62.8%, which reflects premium product positioning and pricing power. ROE of 6.3% indicates moderate return levels that declined from historical performance due to current period profit compression. Operating margin of 10.7% represents solid profitability in absolute terms, though the YoY decline of 17.4% in operating income suggests competitive or cost pressures. The equity ratio of 84.9% positions the company at the conservative end of capital structure spectrum, with minimal financial leverage compared to industry peers who typically maintain higher debt utilization. This fortress balance sheet provides substantial financial flexibility but also indicates potential underutilization of capital structure optimization for ROE enhancement. The company's cash generation capability, evidenced by operating cash flow of 53.8B yen and operating CF to net income ratio of 1.57x, demonstrates superior cash conversion relative to reported earnings quality. Revenue growth of 3.0% YoY reflects stable but modest expansion in a mature market environment. The elevated payout ratio of 82.7% and total return ratio exceeding 100% positions the company as highly shareholder-oriented, though sustainability warrants monitoring given current earnings levels. Working capital metrics, particularly extended inventory days, suggest operational efficiency opportunities compared to lean manufacturing peers in consumer goods sectors.
The company exhibits a dual-profile characterized by strong fundamental business quality offset by temporary profit headwinds and aggressive capital allocation. The maintained gross margin of 62.8% demonstrates resilient core business economics and brand strength, providing a stable revenue base despite operating profit volatility. The structural challenge centers on SG&A expense management, where the 52.1% expense ratio suggests opportunities for operational leverage improvement as revenue scales. The combination of non-recurring investment valuation losses of 8.1B yen and elevated SG&A expenses suppressed current period profitability, but these factors present potential normalization opportunities if management executes forecasted improvements. Cash flow quality remains robust with operating cash flow coverage of 1.57x net income, indicating earnings are well-supported by actual cash generation despite balance sheet working capital concerns. The inventory position warrants close monitoring as extended holding periods signal either demand softness, supply chain overbuilding, or product lifecycle management issues that could crystallize into write-downs or margin pressure. The capital allocation strategy reflects strong shareholder focus through total distributions of 48.6B yen (158% of net income), though this pace exceeds sustainable levels at current earnings and relies on balance sheet cash deployment, suggesting potential for dividend policy recalibration if profitability does not recover as guided. The company's fortress balance sheet with 84.9% equity ratio and 378.7% current ratio provides substantial cushion for near-term uncertainty but also represents underutilized financial capacity that could enhance returns through strategic deployment.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.